Treatment of children and young adults with a Fontan circulation and cardiovascular dysfunction. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ISACHD, ISHLT and PICS
Treatment of children and young adults with a Fontan circulation and cardiovascular dysfunction. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ISACHD, ISHLT and PICS. // The Journal of Heart and Lung Transplantation. – URL: https://www.sciencedirect.com/science/article/pii/S1053249825024763?dgcid=rss_sd_all
Treatment of children and young adults with a Fontan circulation and cardiovascular dysfunction. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ISACHD, ISHLT and PICS. The Journal of Heart and Lung Transplantation. https://www.sciencedirect.com/science/article/pii/S1053249825024763?dgcid=rss_sd_all
“Treatment of children and young adults with a Fontan circulation and cardiovascular dysfunction. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ISACHD, ISHLT and PICS.” The Journal of Heart and Lung Transplantation.
@article{article90913,
title = {Treatment of children and young adults with a Fontan circulation and cardiovascular dysfunction. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ISACHD, ISHLT and PICS},
journal = {The Journal of Heart and Lung Transplantation},
url = {https://www.sciencedirect.com/science/article/pii/S1053249825024763?dgcid=rss_sd_all}
}